Invasive carcinoma of the vulva. Changing trends in surgical management

Am J Obstet Gynecol. 1990 Sep;163(3):1007-15. doi: 10.1016/0002-9378(90)91114-r.

Abstract

Four hundred fifteen patients who had invasive carcinoma of the vulva were treated with primary surgery from July 1, 1955, through June 30, 1989. Three hundred seventy-six (90%) of the patients had squamous carcinoma. Two hundred fourteen patients (52%) had radical vulvectomy with inguinofemoral lymphadenectomy. Twenty-four patients (6%) underwent radical vulvectomy with pelvic exenteration for advanced disease, and 55 patients (13%) had nonradical operations. The remaining 122 patients (29%) underwent radical vulvectomy, inguinofemoral lymphadenectomy, and pelvic lymphadenectomy. The primary morbidity was associated with lymphedema (8.6%) and groin wound breakdown (54%). No intraoperative deaths occurred among the 415 patients treated surgically, but there were 17 deaths (4%) within 28 days of operation. The absolute 5-year survival rate was 85% in patients with negative inguinofemoral lymph nodes and 39% when these lymph nodes were positive for metastatic carcinoma. The overall absolute 5-year survival rate was 67%.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma / mortality
  • Carcinoma / pathology
  • Carcinoma / surgery*
  • Female
  • Humans
  • Lymph Node Excision
  • Middle Aged
  • Morbidity
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local / therapy
  • Neoplasm Staging
  • Survival Rate
  • Vulvar Neoplasms / mortality
  • Vulvar Neoplasms / pathology
  • Vulvar Neoplasms / surgery*